Clinical trial
Phase I Study of Aprotinin in Advanced Breast Cancer
NCT00354900 · Dartmouth-Hitchcock Medical Center, Other · Terminated
Key facts
| NCT number | NCT00354900 |
|---|---|
| Title | Phase I Study of Aprotinin in Advanced Breast Cancer |
| Official title | Phase I Study of Aprotinin in Advanced Breast Cancer |
| Lead sponsor | Dartmouth-Hitchcock Medical Center, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Metastatic Breast Cancer |
| Intervention type | Drug |
| Interventions | Aprotinin |
| Enrollment | 18 |
| Start date | Jul 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Jul 20, 2006 |
| Last update posted | Aug 4, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: